University of Iowa

University of Iowa logo
๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Private
Established
1847-02-25
Employees
251
Market Cap
-
Website
http://www.uiowa.edu
Clinical Trials
Related News

A Phase II Study of Interaction of Lovastatin and Paclitaxel For Patients With Refractory or Relapsed Ovarian Cancer

Phase 2
Terminated
Conditions
Ovarian Cancer
Interventions
Drug: Paclitaxel
Drug: Lovastatin
First Posted Date
2008-01-02
Last Posted Date
2018-01-05
Lead Sponsor
University of Iowa
Target Recruit Count
11
Registration Number
NCT00585052
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Holden Comprehensive Cancer Center, Iowa City, Iowa, United States

Sulodexide Treatment in Patients With Dense Deposit Disease

Phase 1
Withdrawn
Conditions
Dense Deposit Disease
Interventions
Drug: Sulodexide
First Posted Date
2007-12-31
Last Posted Date
2015-06-11
Lead Sponsor
University of Iowa
Registration Number
NCT00583427
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Richard Smith, MD, Iowa City, Iowa, United States

Trental & Vitamin E for Radiation-Induced Fibrosis

Phase 2
Completed
Conditions
Fibrosis
Interventions
Drug: Pentoxifylline
Drug: Vitamin E
First Posted Date
2007-12-31
Last Posted Date
2013-01-29
Lead Sponsor
University of Iowa
Target Recruit Count
54
Registration Number
NCT00583700
Locations
๐Ÿ‡บ๐Ÿ‡ธ

The University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States

Ultrasound Targeting for the Lumpectomy Cavity

Completed
Conditions
Breast Neoplasms
Interventions
Procedure: Ultrasound
First Posted Date
2007-12-31
Last Posted Date
2014-01-16
Lead Sponsor
University of Iowa
Target Recruit Count
20
Registration Number
NCT00583843
Locations
๐Ÿ‡บ๐Ÿ‡ธ

The University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States

Celecoxib as a Post-tonsillectomy Pain Medication

Phase 2
Completed
Conditions
Tonsillitis
Interventions
Drug: Placebo
Drug: Celecoxib
First Posted Date
2007-12-31
Last Posted Date
2017-03-29
Lead Sponsor
University of Iowa
Target Recruit Count
18
Registration Number
NCT00583453
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States

Dose Escalation Phase I/II Study of Lovastatin With High-Dose Cytarabine for Refractory or Relapsed AML

Phase 1
Terminated
Conditions
Acute Myeloid Leukemia
Interventions
Drug: Cytarabine
Drug: Lovastatin
First Posted Date
2007-12-31
Last Posted Date
2018-01-05
Lead Sponsor
University of Iowa
Target Recruit Count
23
Registration Number
NCT00583102
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Holden Comprehensive Cancer Center, Iowa City, Iowa, United States

Yoga to Reduce Cancer Fatigue

Phase 2
Completed
Conditions
Breast Neoplasm
Interventions
Behavioral: Yoga
First Posted Date
2007-12-31
Last Posted Date
2008-12-04
Lead Sponsor
University of Iowa
Target Recruit Count
66
Registration Number
NCT00583739
Locations
๐Ÿ‡บ๐Ÿ‡ธ

The University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States

Improving Walking in Older Adults With Knee Osteoarthritis

Not Applicable
Completed
Conditions
Knee Osteoarthritis
Interventions
Other: Gait Training
First Posted Date
2007-12-31
Last Posted Date
2017-03-10
Lead Sponsor
University of Iowa
Target Recruit Count
27
Registration Number
NCT00583245
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Iowa, Iowa City, Iowa, United States

Phenytoin and Driving Safety: A Randomized, Controlled Cross-Over Study

First Posted Date
2007-12-28
Last Posted Date
2021-07-01
Lead Sponsor
University of Iowa
Target Recruit Count
20
Registration Number
NCT00581893
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States

Evaluation of the Bausch & Lomb PureVision Under Nighttime Driving Conditions

Completed
Conditions
Astigmatism
First Posted Date
2007-12-28
Last Posted Date
2017-04-28
Lead Sponsor
University of Iowa
Target Recruit Count
40
Registration Number
NCT00581659
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Advanced Driving Simulator, Iowa City, Iowa, United States

ยฉ Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy